Mast cell mediator release during refractoriness to mannitol-induced bronchoconstriction

J. Larsson, C. Perry, J. Brannan, S. Anderson, S. E. Dahlén, B. Dahlén (Stockholm, Sweden; Sydney, Australia)

Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Session: Aspects of uncontrolled asthma
Session type: Thematic Poster Session
Number: 1978
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Larsson, C. Perry, J. Brannan, S. Anderson, S. E. Dahlén, B. Dahlén (Stockholm, Sweden; Sydney, Australia). Mast cell mediator release during refractoriness to mannitol-induced bronchoconstriction. Eur Respir J 2009; 34: Suppl. 53, 1978

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sodium cromoglycate inhibits release of mast cell mediators and bronchoconstriction following hyperpnea in athletes
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

Beta adrenergic inhibition of mast cell mediator release in the peripheral lung
Source: Eur Respir J 2005; 26: Suppl. 49, 584s
Year: 2005

Salbutamol attenuates nasal symptoms and mast cell degranulation by AMP challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 228s
Year: 2005

Inflammatory mediator release as a consequence of hyperosmolar stimulation of the eosinophil
Source: Eur Respir J 2001; 18: Suppl. 33, 79s
Year: 2001

Inhalation of mannitol, used as a model for exercise-induced bronchoconstriction (EIB), causes release of leukotrienes and a mast cell marker in asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 102s
Year: 2001

Mast cell tryptase induce alarmin release and secretion of pro-inflammatory cytokines from bronchial epithelial cells
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018



AMP nasal provocation elicits mast cell degranulation: inhibition by topical heparin
Source: Eur Respir J 2004; 24: Suppl. 48, 590s
Year: 2004

Inhibition of IgE-induced airway smooth muscle cell constriction by the anti-IgE-antibody omalizumab
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008

Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions
Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions
Year: 2005


Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression
Source: Eur Respir J 2003; 22: 290-297
Year: 2003



Oral presentation: Sphingosine-1-phosphate administration in vivo induces airway inflammation and hypereactivity in a IgE-dependent manner
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013


Adenosine, mast cells and mediators in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 548s
Year: 2003

Thrombin stimulates the release of cytokines and histamine from basophils
Source: Annual Congress 2008 - Asthma: mechanisms and treatment
Year: 2008

Carbachol – induced proinflammatory cytokine release from immortalised bronchial epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006

Mechanisms of acetylcholine-induced release of proinflammatory extracellular vesicles by endothelial cells and inhibitory effects of tiotropium
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019


Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012


Effect of allergen-activated eosinophils on contractility and migration of ASMC and PF in asthma
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Airway smooth muscle-derived fractalkine needs VIP to induce mast cell chemotaxis
Source: Eur Respir J 2005; 26: Suppl. 49, 128s
Year: 2005